ULTRAGENYX PHARMACEUTICAL INC (RARE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RARE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RARE | Chief Executive Officer of ReCode Therapeutics | 54 | ["Chief Executive Officer of ReCode Therapeutics", "President and Chief Operating Officer of Alector, Inc.", "Senior Vice President, Corporate Development and Strategy of Theravance Biopharma, Inc.", "Group Leader and Project Team Leader at Genentech, Inc.", "Vice President and Global Therapeutic Head, Roche Partnering", "management roles at Gilead Sciences, Inc.", "investment banker with Lehman Brothers and Petkevich & Partners", "member of the board of directors of 10X Genomics, Inc.", "M.D. from the University of Cape Town Medical School", "M.B.A, with distinction, and M.Phil. in Development Studies from Oxford University"] | [] | 2026 |